Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 2
1961 2
1962 2
1964 2
1966 5
1967 5
1968 6
1969 6
1970 5
1971 4
1972 10
1973 12
1974 8
1975 23
1976 31
1977 24
1978 20
1979 14
1980 14
1981 24
1982 24
1983 19
1984 36
1985 45
1986 52
1987 78
1988 75
1989 80
1990 73
1991 84
1992 74
1993 97
1994 91
1995 106
1996 75
1997 86
1998 69
1999 66
2000 71
2001 71
2002 71
2003 82
2004 91
2005 88
2006 105
2007 116
2008 100
2009 97
2010 95
2011 129
2012 136
2013 159
2014 189
2015 153
2016 126
2017 121
2018 127
2019 54
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

3,403 results
Results by year
Filters applied: . Clear all
Page 1
Management of Carfilzomib-Associated Cardiac Adverse Events.
Mikhael J. Clin Lymphoma Myeloma Leuk 2016 - Review. PMID 26907720
Cardiac and cardiopulmonary adverse events have been reported to be associated with carfilzomib-based treatment regimens. This article discusses the cardiac-related adverse events that have been reported in clinical studies of carfilzomib and presents a single institution perspective on the prevention and management of cardiac adverse events following treatment with this agent....
Cardiac and cardiopulmonary adverse events have been reported to be associated with carfilzomib-based treatment regimens. This articl …
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis.
Waxman AJ, et al. JAMA Oncol 2018. PMID 29285538 Free PMC article.
Pooled incidence rates and relative risks (for randomized trials) and 95% confidence intervals were calculated using a random effects model. ...MAIN OUTCOMES AND MEASURES: Cardiovascular adverse events were defined as heart failure, hypertension, ischemia, and arrhythmia. ...
Pooled incidence rates and relative risks (for randomized trials) and 95% confidence intervals were calculated using a random effects
Health Implications Associated with Aspartame Consumption: A Substantial Review
Naik AQ, et al. Pak J Biol Sci 2018 - Review. PMID 30187722
Although research findings in humans and non-human primates have demonstrated numerous negative effects of aspartame (biochemical, histological, neurological, behavioral, genetic etc)., the status of aspartame is still debatable. ...Purpose of this review was to spread the awareness about adverse effect of aspartame intake to outline the occurrence of health issues among the population. ...
Although research findings in humans and non-human primates have demonstrated numerous negative effects of aspartame (biochemical, hi …
Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock
Bauer SR, et al. Pharmacotherapy 2018 - Review. PMID 29878459
Although catecholamine vasopressors are considered life-sustaining therapy, they are associated with adverse reactions, and vasopressin and angiotensin II may be used to minimize these adverse effects. ...This review focuses on the known adverse drug effects of vasopressin and angiotensin II while offering potential solutions to minimize harm with these agents. ...
Although catecholamine vasopressors are considered life-sustaining therapy, they are associated with adverse reactions, and vasopress …
Adverse effects of leuprolide acetate depot treatment.
Friedman AJ, et al. Fertil Steril 1993. PMID 8425646
A smaller percentage of women experienced transient adverse effects due to the initial surge and subsequent rapid decline of gonadal steroids. The mechanism of other adverse effects (e.g., arthralgias) remains unclear. Only 6% of women terminated LA treatment before 12 weeks because of the severity of adverse effects....
A smaller percentage of women experienced transient adverse effects due to the initial surge and subsequent rapid decline of g …
Poisoning from the Kambô ritual
Kumachev A, et al. CJEM 2018. PMID 29706145
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril
Irvin JD and Viau JM. Am J Med 1986 - Review. PMID 3022584
Adverse effects are reviewed as those associated with sulfhydryl compounds and as those considered class-specific adverse effects of angiotensin converting enzyme inhibitors. ...It is concluded from the review of these safety data that enalapril is well tolerated, has few class-specific adverse effects, and may offer a potential advantage over captopril by having fewer sulfhydryl-related adverse effects....
Adverse effects are reviewed as those associated with sulfhydryl compounds and as those considered class-specific adverse
3,403 results
Jump to page
Feedback